Keywords

• Appeal
• Competition
• Agreements, decisions and concerted practices
• Rights of the defence
• Regulation (EC) No 1/2003
• Article 101 TFEU
• Calculation of the amount of the fine
• Reasonable time
• Potential competition
• Pharmaceutical products
• Market for antidepressants (citalopram)
• Settlement agreements relating to disputes concerning process patents concluded by a manufacturer of originator medicines who is the holder of those patents and manufacturers of generic medicines
• Restriction by object
• Characterisation
• Loss of documents due to the passage of time
• General duty of care
• Second subparagraph of Article 23(2)
• Maximum amount of the fine
• Taking into account the business year preceding that in which the European Commission’s decision was adopted
• Last full year of normal economic activity.